OraSure Technologies, Inc. (NASDAQ:OSUR)

CAPS Rating: 2 out of 5

The Company develops, manufactures and markets oral specimen collection devices using its proprietary oral fluid technologies, diagnostic products including in vitro diagnostic tests, and other medical devices.

Recs

1
Player Avatar SoMch2Knw (85.33) Submitted: 8/19/2006 1:25:04 AM : Outperform Start Price: $6.47 OSUR Score: +44.81

OraSure Technologies Inc. has a "point-of-care" test for HIV. I expect it will become a standard test at the emergency room and possibly other locations/situations involving contact between patient/professional. Of course, the 'big sell' is distribution OTC. As that is some time in the future, Mr.Market is currently offering a nice buy-in price.

Featured Broker Partners


Advertisement